4th Annual Observational Sciences for Decision-Making 2013

Topics

• Patient-Reported Outcomes (PRO) and Comparative Effectiveness Research (CER)
• Determine company strategy by assesing the global expectations for health outcomes research and value propositions
• Strengthen evidence-based medicine and present information to players
• Internal HEOR team - function and set priorities
• Measure the data and identifying ways to improve it to set the drug/product apart from others in the eyes of the payers
• Techniques to account for health care reform and a shift to patient-centric medicine

Who should Attend

Executives responsible for:

• Comparative Effectiveness Research
• Health Economics & Outcomes Research
• Reported Outcomes
• Patient
• Epidemiology
• Medical Affairs
• Based medicine
• Evidence
• Pharmacoeconomics
• Market Access/Managed Markets
• Health Technology Assessment (HTA)
• Payer Access/Strategy